Company / Current Assets
Johnson & Johnson Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$55.6B
FY2025
5-year range
$53.5B / $61.0B
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#2 of 213
Health Care
What the data says
Among 213 Health Care companies, Johnson & Johnson is in the top 1% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $43.1B in FY2017 to $65.0B in FY2016.
Based on SEC 10-K filings.
$55.6B in FY2025 with a 5-year CAGR of +1.7%. Ranks 2nd among 213 companies in Health Care.
Improved from $53.5B to $55.6B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +0.2%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 213This company $55.6B Sector average $2.5B
▼
+2104.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.7%, indicating consistent growth.
- In FY2025, current assets decreased 0.5% year-over-year.
- Ranks #2 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.6B | -0.5% |
| FY2024 | $55.9B | +4.5% |
| FY2023 | $53.5B | -3.3% |
| FY2022 | $55.3B | -9.3% |
| FY2021 | $61.0B | +19.0% |
| FY2020 | $51.2B | +13.2% |
| FY2019 | $45.3B | -1.6% |
| FY2018 | $46.0B | +6.8% |
| FY2017 | $43.1B | -33.7% |
| FY2016 | $65.0B | +8.0% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026